top of page

Celexa (citalopram) FDA statment

Celexa 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation

Common Medications with PGx guidelines:

  • Amphetamines & Atomoxetine

  • Amitriptyline, Nortriptyline

  • Aripiprazole, Venlafaxine, Paroxetine & 

    Fluvoxamine

  • Citalopram/Escitalopram

  • Clozapine & Risperidone

  • Atorvastatin, Simvastatin & Rosuvastatin

  • Carvedilol, Metoprolol, Propranolol & Nebivolol

  • Hydralazine

  • Clopidogrel & Warfarin

  • Codeine, Hydrocodone, Oxycodone & Tramadol

  • Meloxicam, Celecoxib & Ibuprofen

  • Carisoprodol

  • Diazepam

  • Donepezil

  • Doxepin

  • Meclizine

  • Phenytoin, carbamazepine & oxcarbazepine

  • Allopurinol

  • Pantoprazole, Omeprazole, dexlansoprazole, esomeprazole & rabeprazole

​​

** And MANY more specialty and oncology treatments which are not listed here 

We use only level A and B evidence to guide specific dosing recommendations and continually evolve based on the current FDA statements and drug labeling, and recommendations endorsed by Clinical Pharmacogenetics Implementation Consortium (CPIC®), managed at Stanford University & St. Jude Children’s Research Hospital.  We also utilize PharmVar (Pharmacogene Variation Consortium) and PharmGKB to help determine what is an "Actionable" PGX result versus "Informative" only. 

CPIC guidelines and clinical support can be found here and PharmVar here. We translate this highly technical information into easily digestible clinical support consult note for each patient, so you have more time with your patients. 

bottom of page